You’re invited to apply or share this opportunity with science research teachers in your fair community.
Regeneron is proud to announce a new science research education outreach program, Activating Science Research Teaching, designed to increase access, capacity and quality of science research education programs. We want to support teachers so they are able to provide more high school students with opportunities to conduct hands-on science research projects.
This new STEM education and outreach program aims to equip science/STEM teachers with knowledge, insights and skills to help them start or strengthen their high school’s science research/STEM program. Three (3) schools will each receive an intensive, one-week of customized consulting sessions facilitated by science research teacher veteran and founder of the award-winning science research program at Yorktown High School in NY, Michael Blueglass. Sessions to be held at or near your high school this upcoming summer. Phone and email support will continue throughout the school year.
Teachers can apply online at the link below. The application deadline is 11:59pm Pacific Time on Tuesday, April 30. Selected schools will be notified by Wednesday, May 8.
Applicants will be evaluated on the basis of their interest in building and/or growing such a program, readiness and capacity in terms of finances and faculty, as well as their administration’s level of support for this program.
At Regeneron, we believe that scientists are the world’s heroes, and behind every great scientist is a passionate, dedicated and highly-motivated teacher. As a leading biotechnology company committed to creating a strong scientific talent pipeline, we focus on investing in improving the skills of science educators and creating opportunities for hands-on science research for students.
Thank you in advance for applying or forwarding this to teachers you think may benefit from this opportunity. If you have any questions, please don’t hesitate to contact me.
Director, Corporate Citizenship
Regeneron Pharmaceuticals, Inc.